Your search returned 2 results.

Sort
Unhighlight Highlight
Select all Clear all
Select titles to:
Results
1.
Factor VIII Inhibitor Bypassing Activity (FEIBA) Reversal for Apixaban and Rivaroxaban in Patients With Acute Intracranial and Nonintracranial Hemorrhage. MedStar authors:
  • Coffeen, Shawn N
PMID:
  • 33843267
Year: 2021
Citation:
  • Annals of Pharmacotherapy. 55(12):1455-1466, 2021 12.
Institution:
  • MedStar Montgomery Medical Center
Medline publication type:
  • Journal Article
Form of publication:
  • Journal Article
All authors:
  • Coffeen SN, Hunt AR, Ice C, Parker J, Shiltz DL
DOI:
Add to cart
2.
Albumin and bleed risk in rivaroxaban treated patients. MedStar authors:
  • Rossi, M
PMID:
  • 32279215
Year: 2020
Citation:
  • Journal of Thrombosis & Thrombolysis. 50(4):1004-1011, 2020 Nov.
Institution:
  • MedStar Union Memorial Hospital
Medline publication type:
  • Journal Article
Form of publication:
  • Journal Article
All authors:
  • Chen L, Cheruvil C, Hassan A, Holsen MR, Rossi M, Wilcox N, Wojakowski E
DOI:
Add to cart
Pages

Powered by Koha